The immunobiology of cancer immunosurveillance and immunoediting

Gavin P. Dunn, Lloyd J. Old, Robert D. Schreiber

Research output: Contribution to journalReview articlepeer-review

2249 Scopus citations


The last fifteen years have seen a reemergence of interest in cancer immunosurveillance and a broadening of this concept into one termed cancer immunoediting. The latter, supported by strong experimental data derived from murine tumor models and provocative correlative data obtained by studying human cancer, holds that the immune system not only protects the host against development of primary nonviral cancers but also sculpts tumor immunogenicity. Cancer immunoediting is a process consisting of three phases: elimination (i.e., cancer immunosurveillance), equilibrium, and escape. Herein, we summarize the data supporting the existence of each of the three cancer immunoediting phases. The full understanding of the immunobiology of cancer immunosurveillance and immunoediting will hopefully stimulate development of more effective immunotherapeutic approaches to control and/or eliminate human cancers.

Original languageEnglish
Pages (from-to)137-148
Number of pages12
Issue number2
StatePublished - Aug 2004


Dive into the research topics of 'The immunobiology of cancer immunosurveillance and immunoediting'. Together they form a unique fingerprint.

Cite this